InMed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.About INM
InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. It operates through the InMed Pharma and BayMedica Commercial segments.
CEOEric A. Adams
CEOEric A. Adams
Employees13
Employees13
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded1981
Founded1981
Employees13
Employees13
INM Key Statistics
Market cap4.81M
Market cap4.81M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume54.31K
Average volume54.31K
High today$1.73
High today$1.73
Low today$1.70
Low today$1.70
Open price$1.72
Open price$1.72
Volume18.18K
Volume18.18K
52 Week high$8.27
52 Week high$8.27
52 Week low$1.67
52 Week low$1.67
Stock Snapshot
The current InMed Pharmaceuticals(INM) stock price is $1.72, with a market capitalization of 4.81M. The stock trades at a price-to-earnings (P/E) ratio of -0.19.
During the trading session on 2025-11-06, InMed Pharmaceuticals(INM) shares reached a daily high of $1.73 and a low of $1.70. At a current price of $1.72, the stock is +0.9% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 18.18K, compared to an average daily volume of 54.31K.
Over the past 52 weeks, InMed Pharmaceuticals(INM) stock has traded between a high of $8.27 and a low of $1.67.
Over the past 52 weeks, InMed Pharmaceuticals(INM) stock has traded between a high of $8.27 and a low of $1.67.
People also own
Based on the portfolios of people who own INM. This list is generated using Robinhood data, and it’s not a recommendation.